Journal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 12, Issue 1, Pages 149-173Publisher
AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.01300216
Keywords
-
Categories
Funding
- Vanderbilt Center for Kidney Disease
- National Institutes of Health NIDDK [DK92192-07]
- Veterans Health Affairs HSRD Merit Award [IIR 13-073-3]
Ask authors/readers for more resources
AKI is an increasingly common disorder that is strongly linked to short- and long-term morbidity and mortality. Despite a growing heterogeneity in its causes, providing a timely and certain diagnosis of AKI remains challenging. In this review, we summarize the evolution of AKI biomarker studies over the past few years, focusing on two major areas of investigation: the early detection and prognosis of AKI. We highlight some of the lessons learned in conducting AKI biomarker studies, including ongoing attempts to address the limitations of creatinine as a reference standard and the recent shift toward evaluating the prognostic potential of these markers. Lastly, we suggest current gaps in knowledge and barriers that may be hindering their incorporation into care and a full ascertainment of their value.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available